These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33914397)
1. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications. Fuchs K; Rummler S; Ries W; Helmschrott M; Selbach J; Ernst F; Morath C; Gauly A; Atiye S; Stauss-Grabo M; Giefer M Ther Apher Dial; 2022 Feb; 26(1):229-241. PubMed ID: 33914397 [TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption with regenerating systems in neurological disorders --A single center experience. Hohenstein B; Passauer J; Ziemssen T; Julius U Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315 [TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus. Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316 [TBL] [Abstract][Full Text] [Related]
5. [Immunoadsorption for treatment of dilated cardiomyopathy]. Felix SB; Dörr M; Herda LR; Beug D; Staudt A Internist (Berl); 2008 Jan; 49(1):51-6. PubMed ID: 18071664 [TBL] [Abstract][Full Text] [Related]
6. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221 [TBL] [Abstract][Full Text] [Related]
7. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms. Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275 [TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques. Burgstaler EA; Cooper LT; Winters JL J Clin Apher; 2007; 22(4):224-32. PubMed ID: 17610291 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? Schmaldienst S; Müllner M; Goldammer A; Spitzauer S; Banyai S; Hörl WH; Derfler K Rheumatology (Oxford); 2001 May; 40(5):513-21. PubMed ID: 11371659 [TBL] [Abstract][Full Text] [Related]
11. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy. Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion. Speer C; Kälble F; Pego da Silva L; Nusshag C; Schaier M; Becker LE; Klein K; Beimler J; Sommerer C; Leo A; Süsal C; Mehrabi A; Zeier M; Morath C Atheroscler Suppl; 2019 Dec; 40():68-72. PubMed ID: 31447215 [TBL] [Abstract][Full Text] [Related]
13. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Greinacher A; Friesecke S; Abel P; Dressel A; Stracke S; Fiene M; Ernst F; Selleng K; Weissenborn K; Schmidt BM; Schiffer M; Felix SB; Lerch MM; Kielstein JT; Mayerle J Lancet; 2011 Sep; 378(9797):1166-73. PubMed ID: 21890192 [TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption in patients with dilated cardiomyopathy. Herda LR; Felix SB; Staudt A Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390 [TBL] [Abstract][Full Text] [Related]
15. Current topics on immunoadsorption therapy. Nakaji S Ther Apher; 2001 Aug; 5(4):301-5. PubMed ID: 11724516 [TBL] [Abstract][Full Text] [Related]
16. Post-Transplantation Immunoadsorption Can Be Withheld in ABO-Incompatible Kidney Transplant Recipients. de Weerd AE; van Agteren M; Ijzermans JN; Weimar W; Betjes MG Ther Apher Dial; 2015 Oct; 19(5):513-7. PubMed ID: 26219347 [TBL] [Abstract][Full Text] [Related]
18. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins. Koll RA Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717 [TBL] [Abstract][Full Text] [Related]
19. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy. Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547 [TBL] [Abstract][Full Text] [Related]
20. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]